This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

27 - 29 May, 2026

Congress CenterBasel Switzerland

Dr. Adam Lodge, PhD
Associate Director, Research at Iksuda Therapeutics
Speaker

Profile

Adam Lodge is an Associate Director at IKSUDA Therapeutics, leading the research team in the design, validation and development of antibody-drug conjugates (ADC) for hard-to-treat cancers. Adam joined IKSUDA Therapeutics in 2016 following a PhD in Molecular Microbiology at Newcastle University.

Agenda Sessions

Designing Best in Class Antibody-drug Conjugates (ADCs) for the Treatment of Cancer
28 May, 08:50
View Session

At this event

Prev

Next

Niccolo Pengo, PhD

Chief Scientific Officer